Article
ASCL1 phosphorylation and ID2 upregulation are roadblocks to glioblastoma stem cell differentiation
11 Feb 2022
Abstract excerpt
The growth of glioblastoma (GBM), one of the deadliest adult cancers, is fuelled by a subpopulation of stem/progenitor cells, which are thought to be the source of resistance and relapse after treatment. Re-engagement of a latent capacity of these cells to re-enter a trajectory resulting in cell differentiation is a potential new therapeutic approach for this devastating disease. ASCL1, a proneural transcription...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
